1. Home
  2. LFCR vs HCAT Comparison

LFCR vs HCAT Comparison

Compare LFCR & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFCR
  • HCAT
  • Stock Information
  • Founded
  • LFCR 1986
  • HCAT 2008
  • Country
  • LFCR United States
  • HCAT United States
  • Employees
  • LFCR N/A
  • HCAT N/A
  • Industry
  • LFCR Biotechnology: Pharmaceutical Preparations
  • HCAT Computer Software: Programming Data Processing
  • Sector
  • LFCR Health Care
  • HCAT Technology
  • Exchange
  • LFCR Nasdaq
  • HCAT Nasdaq
  • Market Cap
  • LFCR 308.8M
  • HCAT 265.9M
  • IPO Year
  • LFCR N/A
  • HCAT 2019
  • Fundamental
  • Price
  • LFCR $7.37
  • HCAT $2.92
  • Analyst Decision
  • LFCR Buy
  • HCAT Buy
  • Analyst Count
  • LFCR 4
  • HCAT 11
  • Target Price
  • LFCR $8.00
  • HCAT $6.18
  • AVG Volume (30 Days)
  • LFCR 125.1K
  • HCAT 831.0K
  • Earning Date
  • LFCR 08-07-2025
  • HCAT 08-07-2025
  • Dividend Yield
  • LFCR N/A
  • HCAT N/A
  • EPS Growth
  • LFCR N/A
  • HCAT N/A
  • EPS
  • LFCR N/A
  • HCAT N/A
  • Revenue
  • LFCR $128,867,000.00
  • HCAT $316,093,000.00
  • Revenue This Year
  • LFCR $4.10
  • HCAT $11.21
  • Revenue Next Year
  • LFCR $14.29
  • HCAT $9.12
  • P/E Ratio
  • LFCR N/A
  • HCAT N/A
  • Revenue Growth
  • LFCR 0.47
  • HCAT 5.55
  • 52 Week Low
  • LFCR $3.68
  • HCAT $2.52
  • 52 Week High
  • LFCR $8.85
  • HCAT $9.24
  • Technical
  • Relative Strength Index (RSI)
  • LFCR 47.91
  • HCAT 36.83
  • Support Level
  • LFCR $7.03
  • HCAT $2.52
  • Resistance Level
  • LFCR $7.87
  • HCAT $3.29
  • Average True Range (ATR)
  • LFCR 0.40
  • HCAT 0.26
  • MACD
  • LFCR 0.01
  • HCAT -0.08
  • Stochastic Oscillator
  • LFCR 53.70
  • HCAT 25.39

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Share on Social Networks: